ArticleResearch square2025

Longitudinal pharmacokinetic and safety studies for dose optimization of a brain- penetrating erythropoietin for Alzheimer's disease.

Rudy Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.